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A 38-year-old male was admitted to theDepartment of Dermatology, Complejo Hospitalario de Granada, Granada, Spain, 
in 2016 with inflamed papules, plaques and nodules 
in the armpits, chest, pubis and lumbar region 
[Figure 1]. He had a history of poorly-controlled type 
2 diabetes, which was being treated with insulin, and 
dyslipidaemia, treated with 40 mg of simvastatin per 
day. The skin lesions were associated with abscess 
formation and spontaneous drainage. The patient 
acknowledged a past history of cocaine abuse, but 
denied any recent drug use. The results of a laboratory 
work-up were normal, including a complete blood 
count, general biochemistry tests, an autoimmune 
profile, an antinuclear antibody panel, a lupus 
anticoagulant and cryoglobulin work-up, a C-reactive 
protein test, complement levels and erythrocyte 
sedimentation rate. The patient tested negative for 
hepatitis B, hepatitis C and human immunodeficiency 
virus infections. A computed tomography scan showed 
neither pulmonary nor abdominal anomalies. Cutan- 
eous tissue cultures for bacteria, fungi and myco-
bacteria were all negative. The initial differential 
diagnosis included cutaneous chronic lupus and 
atypical mycobacteriosis. 
An excisional biopsy was performed on an active 
lesion on the right side of the chest. Histopathology 
revealed a dense neutrophilic inflammatory infiltrate 
involving the entire dermis, without granulomas or 
vasculitis [Figure 2]. Direct immunofluorescence test- 
ing was negative. Urine toxicology screening was 
positive for cocaine and levamisole. As a result of 
the clinical and pathological findings, a diagnosis of 
pyoderma gangrenosum (PG) was made. The patient 
was advised to stop using cocaine and was pres-
cribed prednisone at a dose of 60 mg daily for a 
month, reduced by 5 mg per week until cessation. 
Unfortunately, due to patient noncompliance, optimal 
control of the dermatological condition could not 
be achieved. Continued use of cocaine resulted in 
ongoing PG flare-ups. The patient was subsequently 
prescribed 0.5 mg/kg/day of prednisone, although 
Figure 1: A: Erythematous-violaceous ulcerated plaques on the right armpit and chest of a 38-year-old male cocaine user. 
B: Erythematous plaques with serous crusts on the back of the patient, with small disseminated ulcers surrounding the 
major lesions.
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lupus and granulomatosis with polyangiitis. Infectious 
diseases such as atypical mycobacteriosis, an emerging 
disease in Spain, were also considered.2 
Keith et al. previously reported an association 
between PG and the use of levamisole-adulterated 
cocaine.3 Endothelial damage due to the direct 
toxic effect of cocaine and vasculopathy caused by 
levamisole have been postulated to be the major 
pathophysiological mechanisms in these types of 
cases.4 The therapeutical approach may be compli-
cated; the severity of PG influences the choice 
of the initial therapy. Systemic therapy—such as 
corticosteroids, immunosuppressive therapy or even 
biological therapy—is needed to achieve remission 
in cases of extensive PG; cessation of cocaine use is 
also imperative.5 
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he never completed treatment cycles for longer than 
three weeks. After one year, the patient was lost 
to follow-up.
Comment
PG is an uncommon neutrophilic dermatosis that 
presents as an inflammatory and ulcerative disorder 
of the skin. Most cases are associated with an 
underlying immunological condition, such as inflam- 
matory bowel disease, rheumatological diseases, 
haematological disorders or metabolic syndrome.1 
In the current patient, all of the laboratory tests 
were negative apart from the toxicology screening, 
which distinguishes this case from others reported 
in the literature. The differential diagnosis included 
connective tissue diseases such as chronic cutaneous 
 
Figure 2: Haematoxylin and eosin stain at x40 magni-
fication showing a dense neutrophilic inflammatory 
infiltrate involving the entire dermis, without evidence 
of granulomas or vasculitis.
